Eli Lilly and rival drugmaker Novo Nordisk are the leading companies in the GLP-1 space, but others are emerging. Among them ...

NHS patients risk losing access to the world’s best medicines unless the UK spends more on developing new treatments, the ...

This article analyzes Venezuela’s crisis through the intersecting lenses of international law, military strategy, and ...

One of President Donald Trump’s first-day pledges upon taking office was to secure the U.S. border — a goal that includes ...

Preliminary research suggests that NG101, a drug from Neurogastrx, may lower the risk of nausea and vomiting in people taking ...

Middle-class Indians trying to lose weight are embracing drugs such as Mounjaro, which is also used to treat diabetes in a ...

Merck, which has claimed bragging rights as the maker of the world’s best-selling drug, Keytruda, since 2023, has officially ...

Which is the point of generic drugs. They’re brilliant pharmaceutical representations of what’s true in all walks of ...

Until recently, GLP -1s, a powerful new class of weight-loss drugs, were confined mostly to rich countries. Yet the World ...

Today in health care, aside from the overarching debate about keeping people insured, nothing likely dominates the debates, especially the political ones, more than the cost of prescription drugs.

FREE paradise holidays, unlimited booze and a cash payout – an offer that would likely turn the heads of most naive teenagers ...

China returned two containers of Uruguayan beef after detecting residue of the antiparasitic drug fluazuron, which is used to ...